Research Highlights

Western New Yorkers who were recently exposed to a household member who has tested positive for COVID-19 now have an opportunity to be treated with a promising drug being investigated for COVID-19 infection.  

A team of internationally recognized scientists at the Jacobs School of Medicine and Biomedical Sciences are testing melatonin as a treatment for patients with mild and moderate COVID-19.

Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, was justifiably proud when the announcement of the Nobel Prize in Medicine or Physiology was made in early October.

A powerful partnership that brought University at Buffalo faculty and community leaders together to fight against health disparities has allowed the community to blunt the effect of the coronavirus pandemic on Buffalo’s most vulnerable citizens.

Manoj J. Mammen, MD, associate professor of medicine in the Division of Pulmonary, Critical Care and Sleep Medicine, is one of the co-authors of new clinical practice guidelines for chronic obstructive pulmonary disease (COPD) issued by the American Thoracic Society.

The impact of the global health pandemic on the Jacobs School of Medicine and Biomedical Sciences is far-reaching in terms of its medical education program, residency and fellowship training programs and its research endeavors.

The findings from a recent study by a Jacobs School of Medicine and Biomedical Sciences researcher and others could prove to be a game-changer for men with Type 2 diabetes and the syndrome of hypogonadism.